{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:27:57Z","timestamp":1792052877758,"version":"4.4.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Stroke-induced aphasia significantly impacts communication and quality of life. Despite the standard treatment being speech and language therapy, outcomes vary, highlighting the need for additional therapies. Cerebrolysin, a neuroprotective and neurotrophic agent, has shown potential in stroke management. This study addresses the notable gap in research about the combined use of Cerebrolysin and speech therapy, evaluating their synergistic potential in the treatment of aphasia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>The ESCAS trial (The Efficacy and Safety of Cerebrolysin in the Treatment of Aphasia After Acute Ischemic Stroke), a prospective, randomized-controlled, double-blinded study was conducted in 2 Romanian stroke centers. Participants included those with left middle cerebral artery territory ischemic stroke and nonfluent aphasia, enrolled 3 to 5 days poststroke. Inclusion criteria were right-handedness and Romanian as the mother tongue. Participants received Cerebrolysin or a placebo combined with speech and language therapy in 10-day cycles over 3 intervals, and evaluations were done at baseline, 30, 60, and 90 days respectively. The main outcome measure was Western Aphasia Battery for language function. Changes at days 30, 60, and 90 compared with baseline were quantified, and the effect estimand used was the difference in means between groups. Secondary outcome measurements were the National Institutes of Health Stroke Scale for neurological deficit, the modified Rankin Scale for global disability, and the Barthel Index for activities of daily living.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>\n              Out of 132 enrolled patients, 123 were included in the intention-to-treat analysis, and 120 in the per-protocol analysis. Overall, both groups showed improvement at subsequent visits compared with the baseline for Western Aphasia Battery and the National Institutes of Health Stroke Scale. The Cerebrolysin group showed greater improvements in Western Aphasia Battery (visit 4 mean increase of 35.579\u00b116.316 [95% CI, 31.289\u201339.869] points;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001) compared with the placebo group (20.774\u00b112.486 [95% CI, 17.603\u201323.945] points;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001), a difference in means of 14.805 (95% CI, 9.521\u201320.089) points (\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001). The Cerebrolysin group also showed significant improvements (higher decreases) in National Institutes of Health Stroke Scale scores compared with the placebo group (2.085 [95% CI, 1.076\u20133.094] points;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001). Safety analysis raised no concerns (number of patients with adverse events\n              <jats:italic>P<\/jats:italic>\n              =0.105, number of adverse events per patient\n              <jats:italic>P<\/jats:italic>\n              =0.134). Additionally, the Cerebrolysin group showed greater improvements in functional independence (Barthel Index) and a trend toward reduced disability (modified Rankin Scale) compared with the placebo group.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Cerebrolysin combined with speech and language therapy offers promising potential for enhancing recovery in poststroke nonfluent aphasia. Significant improvements were observed in language and neurological deficits, underscoring the importance of adjunctive therapies in nonfluent aphasia rehabilitation. Further research with larger cohorts is needed to fully establish the efficacy of this combination therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>REGISTRATION:<\/jats:title>\n            <jats:p>\n              URL:\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.isrctn.com\">https:\/\/www.isrctn.com<\/jats:ext-link>\n              ; Unique identifier: ISRCTN54581790.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/strokeaha.124.049834","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T10:00:12Z","timestamp":1739786412000},"page":"937-947","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study"],"prefix":"10.1161","volume":"56","clinical-trial-number":[{"clinical-trial-number":"isrctn54581790","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8449-8681","authenticated-orcid":true,"given":"Volker","family":"Homberg","sequence":"first","affiliation":[{"name":"Department of Neurorehabilitation, SRH Gesundheitszentrum Bad Wimpfen GmbH, Germany (V.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-818X","authenticated-orcid":true,"given":"Drago\u0219 C\u0103t\u0103lin","family":"Jianu","sequence":"additional","affiliation":[{"name":"First Division of Neurology, Department of Neurosciences-VIII, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, Timisoara, Romania (D.C.J.)."},{"name":"Advanced Centre for Cognitive Research in Neuropsychiatric Pathology (NeuroPsy-Cog), Department of Neurosciences-VIII, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, Timisoara, Romania (D.C.J.)."},{"name":"First Department of Neurology, \u201cPius Br\u00eenzeu\u201d Emergency County Hospital, Timisoara, Romania (D.C.J.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8856-4078","authenticated-orcid":true,"given":"Adina","family":"Stan","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, Cluj-Napoca, Romania (A.S., V.-F.C., D.F.M.)."},{"name":"Research Unit, RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania (A.S., S.S., V.-F.C., D.F.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6112-0223","authenticated-orcid":true,"given":"\u0218tefan","family":"Strilciuc","sequence":"additional","affiliation":[{"name":"Department of Genomics, MEDFUTURE Institute for Biomedical Research, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, Cluj-Napoca, Romania (S.S.)."},{"name":"Research Unit, RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania (A.S., S.S., V.-F.C., D.F.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2954-3263","authenticated-orcid":true,"given":"Vlad-Florin","family":"Chelaru","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, Cluj-Napoca, Romania (A.S., V.-F.C., D.F.M.)."},{"name":"Research Unit, RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania (A.S., S.S., V.-F.C., D.F.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6728-2020","authenticated-orcid":true,"given":"Micha\u0142","family":"Karli\u0144ski","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland (M.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8363-4962","authenticated-orcid":true,"given":"Michael","family":"Brainin","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurology, Danube University Krems, Austria (M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf Dieter","family":"Heiss","sequence":"additional","affiliation":[{"name":"Max Planck Institute for Metabolism Research, Cologne, Germany (W.D.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-1153","authenticated-orcid":true,"given":"Dafin F.","family":"Muresanu","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, Cluj-Napoca, Romania (A.S., V.-F.C., D.F.M.)."},{"name":"Research Unit, RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania (A.S., S.S., V.-F.C., D.F.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4371-9053","authenticated-orcid":true,"given":"Pamela M.","family":"Enderby","sequence":"additional","affiliation":[{"name":"Department of Community Rehabilitation, School of Health and Related Research, University of Sheffield, United Kingdom (P.M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.780080"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00252-0"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000425.pub4"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200522020-00006"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu286"},{"key":"e_1_3_3_7_2","volume-title":"Complex Speech-Language Therapy Interventions for Stroke-Related Aphasia: The RELEASE Study Incorporating a Systematic Review and Individual Participant Data Network Meta-Analysis","author":"Brady MC","year":"2022","unstructured":"Brady MC, Ali M, VandenBerg K, Williams LJ, Williams LR, Abo M, Becker F, Bowen A, Brandenburg C, Breitenstein C, et al. Complex Speech-Language Therapy Interventions for Stroke-Related Aphasia: The RELEASE Study Incorporating a Systematic Review and Individual Participant Data Network Meta-Analysis. National Institute for Health and Care Research; 2022. Accessed March 12, 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK584830\/"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07607-9"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Muresanu DF. Neuroplasticity and neurorecovery. Stroke: Practical Guide for Clinicians. In: Bornstein NM ed. 2009. doi: https:\/\/doi.org\/10.1159\/isbn.978-3-8055-9100-3","DOI":"10.1159\/000210271"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2012.01605.x"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009416"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-3037-z"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S75304"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1500459"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051273"},{"key":"e_1_3_3_16_2","unstructured":"Muresanu DF Vester JC. Prospective Meta-Analysis (PMA) of the cerebrolysin trials in neuroprotection and neurorecovery after traumatic brain injury (CAPTAIN I and CAPTAIN II). 2016. Accessed March 12 2024. https:\/\/ssnn.ro\/images\/Images\/Research\/PMA15062016.pdf"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14936"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","unstructured":"Strilciuc S. Safety of Cerebrolysin for neurorecovery after acute ischemic stroke: a systematic review and meta-analysis of twelve randomized-controlled trials; 2021. Accessed March 12 2024. https:\/\/osf.io\/k3c5p\/","DOI":"10.3390\/ph14121297"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-3214-0"},{"key":"e_1_3_3_20_2","first-page":"297","article-title":"Cerebrolysin adjuvant treatment in Broca\u2019s aphasics following first acute ischemic stroke of the left middle cerebral artery.","volume":"3","author":"Jianu DC","year":"2010","unstructured":"Jianu DC, Muresanu DF, Bajenaru O, Popescu BO, Deme SM, Moessler H, Meinzingen SZ, Petrica L. Cerebrolysin adjuvant treatment in Broca\u2019s aphasics following first acute ischemic stroke of the left middle cerebral artery. J Med Life. 2010;3:297\u2013307.","journal-title":"J Med Life"},{"key":"e_1_3_3_21_2","unstructured":"Muresanu DF Verisezan Rosu O. Can Cerebrolysin improve aphasia after ischemic stroke? 2024. Accessed March 12 2024. http:\/\/www.isrctn.com\/ISRCTN54581790"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-18"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1044\/jshd.4503.308"},{"key":"e_1_3_3_24_2","first-page":"74","volume-title":"Afazia \u00een accidentele vasculare cerebrale","author":"Kory Calomfirescu S","year":"1996","unstructured":"Kory Calomfirescu S. Romanian version of Western Aphasia Battery. Afazia \u00een accidentele vasculare cerebrale. In: Kory Calomfirescu S, Kory-Mercea M, Lolo\u0219 R, eds.1996;3:74\u201395."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/02687038.2020.1787947"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2018.08.177"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1044\/2019_AJSLP-CAC48-18-0217"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000015625.87603.a7"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.19.5.604"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/09638288809164103"},{"key":"e_1_3_3_31_2","first-page":"61","article-title":"Functional evaluation: the Barthel index.","volume":"14","author":"Mahoney FI","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61\u201365.","journal-title":"Md State Med J"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.3352\/jeehp.2021.18.17"},{"key":"e_1_3_3_33_2","unstructured":"Wickham H Chang W Henry L Pedersen TL Takahashi K Wilke C Woo K Yutani H Dunnington D van den Brand T et al. ggplot2: create elegant data visualisations using the grammar of graphics; 2024. Accessed March 12 2024. https:\/\/cran.r-project.org\/web\/packages\/ggplot2\/index.html"},{"key":"e_1_3_3_34_2","unstructured":"Wickham H Bryan J. readxl: read excel files; 2023. https:\/\/CRAN.R-project.org\/package=readxl"},{"key":"e_1_3_3_35_2","unstructured":"Dragulescu A Arendt C. xlsx: read write format excel 2007 and excel 97\/2000\/XP\/2003 files; 2020. https:\/\/cran.r-project.org\/web\/packages\/xlsx\/index.html"},{"key":"e_1_3_3_36_2","unstructured":"Friedrich S Konietschke F Pauly M. MANOVA.RM: resampling-based analysis of multivariate data and repeated measures designs; 2023. Accessed March 12 2024. https:\/\/cran.r-project.org\/web\/packages\/MANOVA.RM\/index.html"},{"key":"e_1_3_3_37_2","unstructured":"Revelle W. psych: procedures for psychological psychometric and personality research; 2024. Accessed March 12 2024. https:\/\/cran.r-project.org\/web\/packages\/psych\/index.html"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007026.pub4"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.124.049834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T18:12:30Z","timestamp":1742839950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.124.049834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1161\/STROKEAHA.124.049834"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.124.049834","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-02-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}